During a live event, Andrew Kuykendall, MD, discussed management of anemia before and during use of JAK inhibitor for ...

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

I am 71 years old and was diagnosed with pernicious anemia in October 2024. My B12 and folate levels were low. My ...

A person who has the type of anemia with B12 deficiency and low B12 levels (called "megaloblastic anemia" with unusual white ...

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

Panelists discuss how black box warnings on IV iron products, particularly regarding hypersensitivity reactions, influence their risk assessment, patient selection, monitoring protocols, and facility ...

I am 71 years old and was diagnosed with pernicious anemia in October 2024. My B12 and folate levels were low. My antiparietal antibodies were abnormal, but the ...

I am 71 years old and was diagnosed with pernicious anemia in October 2024. My B12 and folate levels were low. My antiparietal antibodies were abnormal, but the intrinsic factor antibodies were ...

Dear M.P.: Pernicious anemia (PA) is an autoimmune disease where the body destroys the cells in the stomach that make ...

The researchers found that imlunestrant prolonged progression-free survival (PFS) when compared to standard care in patients with ESR1 mutations, but there was no PFS benefit observed in the overall ...

New research found that over half of people with type 2 diabetes in the Americas may be deficient in essential nutrients, ...

Researchers have published findings from the phase 2 LITESPARK-003 study of patients with previously untreated advanced clear ...